Hiroki Kabata
Impact in
- Immunology top 1%
- IL-33, ST2, and ILC Pathways
- Immune Cell Function and Interaction
- Immunology and Allergy top 2%
- Allergic Rhinitis and Sensitization
Papers in
- Immunology 23
- IL-33, ST2, and ILC Pathways 21
- Immune Cell Function and Interaction 9
- Physiology 21
- Asthma and respiratory diseases 20
- Co-authors
- Kazuyo Moro (12 shared papers)Shigeo Koyasu (7 shared papers)Koichi Fukunaga (44 shared papers)Koichiro Asano (16 shared papers)David Artis (4 shared papers)Tomoko Betsuyaku (12 shared papers)Katsunori Masaki (26 shared papers)Jun Miyata (22 shared papers)
- Journals
- Allergology International (9 papers)Journal of Allergy and Clinical Immunology (2 papers)Mucosal Immunology (2 papers)Nature (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hiroki Kabata
60 papers receiving 2.8k citations
Hiroki Kabata's Hit Papers
Peers
Comparison fields: 5 of 115
- Immunology 1.5k
- Immunology and Allergy 188
- Physiology 720
- Surgery 908
- Dermatology 184
Countries citing papers authored by Hiroki Kabata
This map shows the geographic impact of Hiroki Kabata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Kabata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Kabata more than expected).
Fields of papers citing papers by Hiroki Kabata
This network shows the impact of papers produced by Hiroki Kabata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Kabata. The network helps show where Hiroki Kabata may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroki Kabata, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation Hit paper breakdown → | 2017 | 425 |
| 2 | 2015 | 328 | |
| 3 | 2013 | 276 | |
| 4 | 2020 | 266 | |
| 5 | 2018 | 222 | |
| 6 | 2019 | 221 | |
| 7 | 2019 | 144 | |
| 8 | 2015 | 110 | |
| 9 | 2014 | 99 | |
| 10 | 2020 | 86 | |
| 11 | 2022 | 79 | |
| 12 | 2020 | 69 | |
| 13 | 2021 | 65 | |
| 14 | 2015 | 63 | |
| 15 | 2022 | 26 | |
| 16 | 2013 | 23 | |
| 17 | 2020 | 21 | |
| 18 | 2017 | 20 | |
| 19 | 2022 | 17 | |
| 20 | 2022 | 16 |
About Hiroki Kabata
Hiroki Kabata is a scholar working on Immunology, Physiology, Surgery, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 66 papers that have together received 2.8k indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (21 papers), Asthma and respiratory diseases (20 papers), Eosinophilic Esophagitis (14 papers), Immune Cell Function and Interaction (9 papers), COVID-19 Clinical Research Studies (5 papers), Dermatology and Skin Diseases (4 papers), Long-Term Effects of COVID-19 (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). The work is most often cited by research in Immunology (1.5k citations), Immunology and Allergy (188 citations), Physiology (720 citations), Surgery (908 citations) and Dermatology (184 citations). Hiroki Kabata has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Kazuyo Moro, Shigeo Koyasu, Koichi Fukunaga, Koichiro Asano, David Artis, Tomoko Betsuyaku, Katsunori Masaki, Jun Miyata, Gregory Putzel and Yoshihiro Kawaoka. Their work appears in journals such as Allergology International, Journal of Allergy and Clinical Immunology, Mucosal Immunology, Nature and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.